To identify the most effective dosing regimen for indigent patients with low-risk gestational trophoblastic neoplasia (GTN) at high risk of noncompliance.
Southwestern Trophoblastic Disease Center, Division of Gynecologic Oncology, Dep. of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, 75390-9032, USA. john.schorge@utsouthwestern.edu